Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Oncology 11 (2021): 672172.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2021
- Urheber
-
Kähler, Katharina C.
Gutzmer, Ralf
Meier, Friedegrund
Zimmer, Lisa
Heppt, Markus
Gesierich, Anja
Thoms, Kai-Martin
Utikal, Jochen
Hassel, Jessica C.
Loquai, Carmen
Pföhler, Claudia
Heinzerling, Lucie
Kaatz, Martin
Göppner, Daniela
Pflugfelder, Annette
Bohne, Ann-Sophie
Satzger, Imke
Reinhardt, Lydia
Placke, Jan-Malte
Schadendorf, Dirk
Ugurel, Selma
- DOI
-
10.3389/fonc.2021.672172
- URN
-
urn:nbn:de:bvb:29-opus4-165333
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kähler, Katharina C.
- Gutzmer, Ralf
- Meier, Friedegrund
- Zimmer, Lisa
- Heppt, Markus
- Gesierich, Anja
- Thoms, Kai-Martin
- Utikal, Jochen
- Hassel, Jessica C.
- Loquai, Carmen
- Pföhler, Claudia
- Heinzerling, Lucie
- Kaatz, Martin
- Göppner, Daniela
- Pflugfelder, Annette
- Bohne, Ann-Sophie
- Satzger, Imke
- Reinhardt, Lydia
- Placke, Jan-Malte
- Schadendorf, Dirk
- Ugurel, Selma
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2021
Ähnliche Objekte (12)
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Discontinuation of BRAF/MEK-directed targeted therapy after complete remission of metastatic melanoma — a retrospective multicenter ADOReg study
Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment—A Retrospective Multicenter Analysis
Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study
Favorable
Clinical determinants of long-term survival in metastatic uveal melanoma
Antibody-Mediated Status Epilepticus: A Retrospective Multicenter Survey
Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma : a retrospective multicenter DeCOG study
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : : a retrospective multicenter study
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Contestación favorable
Contestación favorable
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Discontinuation of BRAF/MEK-directed targeted therapy after complete remission of metastatic melanoma — a retrospective multicenter ADOReg study
Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment—A Retrospective Multicenter Analysis
Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study
Favorable
Clinical determinants of long-term survival in metastatic uveal melanoma
Antibody-Mediated Status Epilepticus: A Retrospective Multicenter Survey
Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma : a retrospective multicenter DeCOG study
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : : a retrospective multicenter study
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Contestación favorable
Contestación favorable
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Discontinuation of BRAF/MEK-directed targeted therapy after complete remission of metastatic melanoma — a retrospective multicenter ADOReg study
Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment—A Retrospective Multicenter Analysis
Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study
Favorable
Clinical determinants of long-term survival in metastatic uveal melanoma
Antibody-Mediated Status Epilepticus: A Retrospective Multicenter Survey
Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma : a retrospective multicenter DeCOG study
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : : a retrospective multicenter study
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Contestación favorable